Why the study?
Does chronic aspirin therapy increase the incidence of gastric lesions in patients with rheumatic disease?
Population
82 patients with rheumatic disease receiving chronic aspirin therapy.
Comparison
Chronic aspirin therapy. vs 45 normal subjects not taking aspirin.
Design
Cross-sectional
Authors
Loading...
May raise gastric lesion risk in chronic aspirin users; leaves open enteric-coated benefits in prospective trials.
Does chronic aspirin therapy increase the incidence of gastric lesions in patients with rheumatic disease?
Chronic aspirin therapy in rheumatic disease patients is associated with a high incidence of potentially asymptomatic gastric ulcers and erosions, though enteric-coated formulations may reduce this risk.
G.R. Silvoso (1979) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: